Yliskoski M - Search Results

1

Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors.

Hiltunen EL, Anttila M, Kultti A, Ropponen K, Penttinen J, Yliskoski M, Kuronen AT, Juhola M, Tammi R, Tammi M, Kosma VM. Hiltunen EL, et al. Among authors: yliskoski m. Cancer Res. 2002 Nov 15;62(22):6410-3. Cancer Res. 2002. PMID: 12438225

2

Management of stage-I borderline ovarian tumors.

Ji H, Yliskoski M, Anttila M, Syrjänen K, Saarikoski S. Ji H, et al. Among authors: yliskoski m. Int J Gynaecol Obstet. 1996 Jul;54(1):37-44. doi: 10.1016/0020-7292(96)02674-4. Int J Gynaecol Obstet. 1996. PMID: 8842816

3

A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: the Finnish Ovarian Cancer (FINOVA) study.

Grénman S, Wiklund T, Jalkanen J, Kuoppala T, Mäenpää J, Kuronen A, Leminen A, Puistola U, Vuolo-Merilä P, Salmi T, Vuento M, Yliskoski M, Itälä M, Helenius H, Joensuu H, Lehtovirta P. Grénman S, et al. Among authors: yliskoski m. Eur J Cancer. 2006 Sep;42(14):2196-9. doi: 10.1016/j.ejca.2006.03.021. Epub 2006 Aug 8. Eur J Cancer. 2006. PMID: 16893642 Clinical Trial.

4

Expression of transforming growth factor-beta 1 and -beta 2 in human papillomavirus (HPV)-associated lesions of the uterine cervix.

Tervahauta A, Syrjänen S, Yliskoski M, Gold LI, Syrjänen K. Tervahauta A, et al. Among authors: yliskoski m. Gynecol Oncol. 1994 Sep;54(3):349-56. doi: 10.1006/gyno.1994.1222. Gynecol Oncol. 1994. PMID: 8088612 Free article.

5

Oral mucosal changes in women with genital HPV infection.

Kellokoski J, Syrjänen S, Syrjänen K, Yliskoski M. Kellokoski J, et al. Among authors: yliskoski m. J Oral Pathol Med. 1990 Mar;19(3):142-8. doi: 10.1111/j.1600-0714.1990.tb00813.x. J Oral Pathol Med. 1990. PMID: 1692879

6

Variants of the long control region of human papillomavirus type 16.

Kurvinen K, Yliskoski M, Saarikoski S, Syrjänen K, Syrjänen S. Kurvinen K, et al. Among authors: yliskoski m. Eur J Cancer. 2000 Jul;36(11):1402-10. doi: 10.1016/s0959-8049(00)00121-0. Eur J Cancer. 2000. PMID: 10899654

7

Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System.

Syrjänen K, Kataja V, Yliskoski M, Chang F, Syrjänen S, Saarikoski S. Syrjänen K, et al. Among authors: yliskoski m. Obstet Gynecol. 1992 May;79(5 ( Pt 1)):675-82. Obstet Gynecol. 1992. PMID: 1314359

8

HLA types in women with cervical human papillomavirus (HPV) lesions prospectively followed up for 10 years.

Syrjänen K, Nurmi T, Mäntyjärvi R, Ilonen J, Syrjänen S, Surcel HM, Yliskoski M, Väyrynen M, Chang F, Saarikoski S. Syrjänen K, et al. Among authors: yliskoski m. Cytopathology. 1996 Apr;7(2):99-107. doi: 10.1046/j.1365-2303.1996.38882388.x. Cytopathology. 1996. PMID: 9074659

9

Colposcopic analysis of genital human papillomavirus infections during an 8-year prospective follow-up.

Ji HX, Yliskoski M, Väyrynen M, Hippeläinen M, Syrjänen S, Syrjänen K. Ji HX, et al. Among authors: yliskoski m. Int J Gynaecol Obstet. 1991 Dec;36(4):291-300. doi: 10.1016/0020-7292(91)90483-l. Int J Gynaecol Obstet. 1991. PMID: 1684763

10

Exposure of an infant to cervical human papillomavirus infection of the mother is common.

Puranen MH, Yliskoski MH, Saarikoski SV, Syrjänen KJ, Syrjänen SM. Puranen MH, et al. Among authors: yliskoski mh. Am J Obstet Gynecol. 1997 May;176(5):1039-45. doi: 10.1016/s0002-9378(97)70399-5. Am J Obstet Gynecol. 1997. PMID: 9166165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters